Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus

NCT05043467 is registered in ClinicalTrials.gov with Chong Kun Dang Pharmaceutical as lead sponsor.

NCT NCT05043467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05043467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus
Lead sponsor
Chong Kun Dang Pharmaceutical
Phase
Observational
Overall status
Completed
Start date
January 2, 2019
Completion date
June 19, 2020
Enrollment
2,228 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes